Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study. Cook S, Vermersch P, Comi G, Giovannoni G, Rammohan K, Rieckmann P, Sørensen SP, Hamlett A, Miret M, Weiner J, et al. Mult Scler. 2011 May; 17(5):578-93. Epub 2011 Jan 12. PMID: 21228029. Abstract CommentRecommendBookmarkWatch